QIAGEN and BioHelix Enter Into Licensing Agreement
Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms
QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay technology to detect and analyze biological target molecules such as DNA and RNA by amplifying target specific genetic information with the highest level of sensitivity and specificity. Financial terms were not disclosed.
Unlike conventional amplification technologies such as the polymerase chain reaction (PCR), which requires thermocycling, HDA works at a constant temperature, eliminating the need for complex and costly instrumentation. In addition HDA technology offers a simple reaction workflow and a user-friendly assay design process. Two primers are used to flank the DNA fragment to be amplified, thereby allowing simple and rapid development of new singleplex and/or multiplex assays for use in research, pharmaceutical development, applied markets or molecular diagnostics.
Furthermore, HDA has shown potential for the development of simple, portable DNA diagnostic devices to be used in the field or at the point-of-care..
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
Tiny spiders, big color
Sartorius announces offer to acquire TAP
Observing nanoparticles with unprecedented precision - Illuminated: Researchers investigate new physical phenomena on the nanoscale with microstructured fibers
High-throughput drug screening in 3D
Stanford Scientists Pinpoint Key Proteins in Blood Stem Cell Replication
Chickens and pigs with integrated genetic scissors - Genome editing in farm animals
X-rays show birth of semiconductor for blue LEDs - Gallium nitride is the second most important semiconductor material after silicon
Sartorius Stedim Biotech and Refine Technology Announce Cooperation